|
Showing the most relevant articles for your search:NASDAQ:XNPT 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 | 2017/02/14 | 04 : 21 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:XNPT | Xenoport, Inc. |
2016/08/05 | 05 : 40 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/16 | 01 : 00 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/15 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 23 : 03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 23 : 02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 59 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 58 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 54 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 53 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 50 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 50 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 49 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 45 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 45 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 45 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/14 | 22 : 38 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/13 | 06 : 22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/06 | 05 : 54 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/06 | 02 : 36 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/06 | 02 : 17 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/05 | 21 : 42 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:XNPT | Xenoport, Inc. |
2016/07/05 | 19 : 30 | Business Wire | Arbor Pharmaceuticals Completes Successful Tender Offer for Shares of XenoPort | NASDAQ:XNPT | Xenoport, Inc. |
2016/06/29 | 20 : 45 | PR Newswire (US) | Why Investors Love These Biotech's Stocks? - Cellectar Biosciences, Xenoport, Rexahn Pharma, and Tesaro | NASDAQ:XNPT | Xenoport, Inc. |
2016/06/29 | 02 : 22 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:XNPT | Xenoport, Inc. |
2016/06/28 | 01 : 33 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:XNPT | Xenoport, Inc. |
2016/06/27 | 19 : 13 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:XNPT | Xenoport, Inc. |
2016/06/25 | 06 : 23 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:XNPT | Xenoport, Inc. |
2016/06/21 | 04 : 12 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:XNPT | Xenoport, Inc. |
2016/06/21 | 03 : 43 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:XNPT | Xenoport, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:XNPT |
|